Contact Us

Have questions? 

Please email us at or call us at 780-436-0983 ext.234


123 Street Avenue, City Town, 99999

(123) 555-6789


You can set your address, phone number, email and site description in the settings tab.
Link to read me page with more information.

2019 Program


The 2019 Canadian Liver Meeting offers participants with a forum for presentation and discussion of basic science, translational and clinical aspects of liver disease. This is the 2nd year that delegates will receive the opportunity to exchange ideas, promote collaboration and foster knowledge translation among Canadian researchers, healthcare practitioners and community-based groups with interest in Hepatology. 

The program features Canadian and international speakers, the latest research presentations, state of the art symposia, and a wealth of networking opportunities with peers, trainees, allied health practitioners, and industry.

Saturday, May 25

7:00 AM - 4:00 Pm

Registration Open

7:00 - 7:45 Am

Breakfast Symposia - Pre-registration required


Palliative Care in Patients with End-Stage Liver Disease/Cases

Outremont 5
Cynthia Tsien, University of Ottawa

Difficult Cases in Treating Patients with Hepatitis C

Outremont 4
Matthew Sadler, Foothills Medical Center &
Curtis Cooper, University of Ottawa

7:00 - 8:00 AM

CASL Special Interest Group Meeting

8:00 - 9:15 AM

Concurrent Session


Public Heath: Innovative Approaches to Enhance Testing, Linkage to Care and Treatment for HCV Infection

Montreal 1-3

  • Introduction and Setting the Scene

    Jason Grebely, Canadian Network on Hepatitis C and UNSW Sydney, Australia

  • Nurse Led HCV Micro-Elimination Outreach Project for People with Unstable Housing and Homelessness in Victoria BC

    Tamara Barnett, Cool Aid

  • Enhancing Care for HCV Infection in Prisons in Eastern Canada
    Lisa Barrett, Dalhousie University

  • Accelerated Pre-Treatment Evaluation for Persons who Inject Drugs Disengaged from the Healthcare System in Montréal

    Lisa Barrett, Dalhousie University

9:15 - 9:20 AM

Room Change

9:20 - 10:15 AM

Concurrent Session

HCC Basic/Translational: Molecular Mechanisms of HCC in Viral and Non-Viral Hepatitis

Montreal 4-5

  • Molecular mechanism of HCC in Viral Hepatitis
    Ralf Bartenschlager, Heidelberg University

  • Metabolic Profiling of HCC: In Vitro & In Vivo Models of HCC
    Marc Bilodeau, University of Montreal

  • The Role of the Inflammasome in Gastrointestinal Cancers and Liver Metastasis
    Maya Saleh, McGill University

  • New Medical Therapies for HCC
    Hélène Castel, University of Montreal


CAHN Sessions

Montreal 1-3

  • Welcome


    Donna Zukowski, CAHN President
    Session Moderator: Mary Guyton

  • Nutrition in Liver Disease: Practical Counseling Tips


    Chantal Bemeur, University of Montreal

  • Hepatic Encephalopathy: Nursing Interventions


    Elizabeth Lee, University Health Network

Viral Hepatitis Oral Abstract Presentations

Montreal 4-5

  • Incidence and Predictors of Flares after Stopping Nucleos(t)ide Analogue Therapy in HBeAg Negative Patients with Chronic Hepatitis B: Results from the Randomized Controlled STOP Study
    Scott Fung, Toronto Centre for Liver Disease

  • Global Real World Evidence of Sofosbuvir/Velpatasvir as a Simple, Effective Regimen for the Treatment of Chronic Hepatitis C patients: Integrated Analysis of 12 Clinical Practice Cohorts
    Alnoor Ramji, University of British Columbia

  • Results of a Birth Cohort Hepatitis C Screening Program in an Academic Emergency Department in Canada
    Camelia Capraru, Toronto Centre for Liver Disease/VIRCAN, UHN

  • Noninvasive Prediction of Esophageal Varices by Liver Stiffness Measurement and Platelet Count in 590 HIV-Infected Cirrhotic Patients With and Without HCV Coinfection: Multicenter Validation of Baveno VI Criteria
    Giada Sebastiani, McGill University

  • Prenatal HBsAg Screening Rates and Follow-up DNA Testing Low in Ontario
    Mia Biondi, Toronto General Hospital, UHN

10:15 - 10:45 AM

Break, Poster, & Exhibit Viewing

10:45 - 12:30 PM

Concurrent Session


Mechanisms of Liver Injury & Repair in NAFLD & Viral Hepatitis

Montreal 1-3

  • Immunopathogenesis of Hepatitis B
    Adam Gehring, University of Toronto

  • Analysis of Virus Induced Mechanisms of Programmed Cell Death
    Rodney Russell, Memorial University

  • The Liver as Frontline Immune Organ
    Craig Jenne, University of Calgary

  • Insulin Signaling in NAFLD & NAFLD-related HCC
    Jennifer Estall, McGill University

New Clinical Developments

Montreal 4-5

    Saumya Jayakumar, University of Calgary

  • Alcohol

    Gyongyi Szabo, University of Alberta Hospital

  • Viral Hepatitis
    Mark Sulkowski, Johns Hopkins Medicine

  • The Challenge of Fontan Associated Liver Disease

    Beverley Kok, University of Alberta Hospital

12:30 - 1:30 PM

Lunch, Poster & Exhibit Viewing

St. Laurent 1-3

1:30 - 3:00 Pm

Concurrent Session


Evolving Evidence in Liver Disease Pathogenesis and Best Clinical Management

Montreal 1-3

  • Novel Mechanisms Linking Blood Coagulation to Liver Injury and Regeneration
    Jim Luyendyke, Michigan State University

  • Overview of Hepatitis B Reactivation: Current Concepts, Molecular Mechanisms and Management
    Norah Terrault, USC Keck School of Medicine

  • Translational Research in Alcoholic Hepatitis from iTeam (NIH Consortium)

    Gyongyi Szabo, University of Massachusetts Medical School

  • HCV Treatment in HCC: Yes or No? A Debate
    David Wong, University of Toronto vs. Kelly Burak, University of Calgary

Public Health and Best Practice Clinical Management

Montreal 4-5

  • Nutrition Updates in NAFLD and Cirrhosis
    Maitreyi Raman, University of Calgary

  • Public Health Approaches In Childhood Obesity
    Shazhan Amed, University of British Columbia

  • Up-to-Date Diagnosis & Management of Hepatopulmonary Syndrome and Portopulmonary Hypertension
    Samir Gupta, University of Toronto

3:00 - 3:30 PM

Break, Poster & Exhibit Viewing

St. Laurent 1-3

3:30 - 5:00 PM

CASL-CLF Sass-Kortsak Lecture & Pediatric Symposium

Montreal 4-5

CASL-CLF Sass-Kortsak Lecture
Fernando Alvarez, CHU-Sainte Justine

Biliary Atresia in Long-Term Kasai Survivors
Richard Schreiber, University of British Columbia

Primary Scelrosing Cholangitis
Orlee Guttman, University of British Columbia
Aldo Montano-Loza, University of Alberta

Congenital Hepatic Fibrosis in the Long-Term Outcome of Autosomal Recessive Polycystic Kidney Disease
Steve Martin, University of Calgary


3:30 - 4:30 PM

CAHN Session
HCV Models of Care Among Priority Populations: Nursing Practice and Pearls

Montreal 1-3
Chair: Mia Biondi

  • Prison System
    Dennaye Fuchs, Saskatchewan Health Authority

  • Supervised Injection/Overdose Prevention
    Bernadette Lettner & Kate Mason, South Riverdale Community Health Centre

  • Reaching Homeless Populations
    Jacqueline Atkinson, Mobile Outreach Street Health

  • Newcomer HCV Linkage
    Jeanette Feizi Farivar, GI Research Institute

4:30 - 5:00 PM

The Next Liver Disease of Focus: Alcohol or NASH? A Debate

Montreal 1-3
David Wong, University Health network
Edward Tam, Lair Centre

Chair: Colina Yim, University Health Network

5:00 Pm

CASL Annual General Meeting (CASL Members Only)

Montreal 6-7